©istock.com/Andrea Obzerova
Unsere KompetenzInterdisziplinäre Diagnostik
Know how bei der Analyse von Erbmaterial.
Zum Wohle von Patientinnen und Patienten.

Klinische FragestellungKatarakt, syndromisch; Differentialdiagnose

Zusammenfassung

Kurzinformation

Ein kuratiertes panel mit 123 Genen zur umfassenden Untersuchung von praktisch allen bekannten genetisch bedingten, syndromischen Katarakt-Entitäten

ID
KP0010
Anzahl Gene
121 Akkreditierte Untersuchung
Untersuchte Sequenzlänge
0,0 kb (Core-/Core-canditate-Gene)
268,1 kb (Erweitertes Panel: inkl. additional genes)
Analyse-Dauer
auf Anfrage
Untersuchungsmaterial
  • EDTA-Blut (3-5 ml)
Diagnostische Hinweise

NGS +

[Sanger]

 

Genpanel

Ausgewählte Gene

NameExon-Länge (bp)OMIM-GReferenz-Seq.Erbgang
ABHD121197NM_001042472.3AR
ADAMTS103312NM_030957.4AR
AGK1269NM_018238.4AR
AGPS1977NM_003659.4AR
ALDH18A12388NM_002860.4AD, AR
ANAPC15835NM_022662.4AR
ATAD3A1761NM_001170535.3AR
B3GLCT1497NM_194318.4AR
BCOR5166NM_017745.6XL
CDK91126NM_001261.4AR
COG42295NM_001195139.2AR
COL11A15421NM_001854.4AD, AR
COL18A14560NM_001379500.1AR
COL2A14464NM_001844.5AD
COL4A15010NM_001845.6AD, Mult
COL4A55058NM_000495.5XL
COPB12883NM_001144061.2AR
CRYAA522NM_000394.4AD, AR
CRYAB528NM_001885.3AD, AR
CRYBA4591NM_001886.3AD
CRYBB1759NM_001887.4AD, AR
CRYBB2618NM_000496.3AD
CRYBB3636NM_004076.5AD, AR
CRYGC525NM_020989.4AD
CTDP12529NM_004715.5AR
CYP27A11596NM_000784.4AR
CYP51A11540NM_000786.4XL
DHCR71428NM_001360.3AR
DMPK1920NM_001081563.2AD
DNMBP6032NM_015221.4AD
DYRK1A2292NM_001396.5AD
EED2100NM_003797.5AD
EIF2B21056NM_014239.4AD
EPG57740NM_020964.3AR
EPHA22931NM_004431.5AD
ERCC22283NM_000400.4AR
ERCC32349NM_000122.2AR
ERCC64482NM_000124.4AR
ERCC81191NM_000082.4AR
EYA11779NM_000503.6AD
FAR11548NM_032228.6AR, AD
FBN18616NM_000138.5AD
FOXC11662NM_001453.3AD
FOXE3960NM_012186.3AD, AR
FTL528NM_000146.4AD
GALK11179NM_000154.2AR
GALM1069NM_138801.3AR
GALT1140NM_000155.4AR
GCNT21203NM_001491.3n.k.
GEMIN43177NM_015721.3AR
GFER618NM_005262.3AR
GLS1797NM_001256310.2AD
GNPAT2043NM_014236.4AR
GTF2H5216NM_207118.3AR
HMX11047NM_018942.3AR
HTRA21377NM_013247.5AR
HYCC11566NM_032581.4AR
INPP5K1119NM_016532.4AR
INTS16843NM_001080453.3AR
JAM3780NM_001205329.2AR
LCAT1323NM_000229.2AR
LIM2648NM_030657.4AR
LONP12688NM_001276479.2AR
LSS2303NM_001001438.3AR
MAF1212NM_005360.5AD
MAN2B13036NM_000528.4AR
MED271160NM_001253881.2AR
MSMO1489NM_001017369.3AR
MYH95883NM_002473.6AD
NACC11589NM_052876.4AD
NDP402NM_000266.4XLR
NF21788NM_000268.4AD
NHS4425NM_001136024.4XL
NUP1885294NM_015354.3AD
OCRL2706NM_000276.4XLR
OPA3540NM_025136.4AD
P3H21584NM_001134418.2AR
PAX61269NM_000280.5AD
PEX13852NM_000466.3AR
PEX101041NM_153818.2AR
PEX11B780NM_003846.3AR
PEX121080NM_000286.3AR
PEX131212NM_002618.4AR
PEX141134NM_004565.3AR
PEX161011NM_004813.4AR
PEX19900NM_002857.4AR
PEX2918NM_000318.3AR
PEX26918NM_017929.6AR
PEX31122NM_003630.3AR
PEX51920NM_001131025.2AR
PEX62943NM_000287.4AR
PEX7972NM_000288.4AR
PGRMC1588NM_006667.5AD
PIK3C2A5093NM_002645.4AR
PITX3909NM_005029.4AD
PLOD32217NM_001084.5AR
POLG3720NM_002693.3AD, AR
POMT12244NM_007171.4AR
PSMC31501NM_002804.5AD
PXDN4440NM_012293.3AR
RAB18621NM_021252.5AR
RAB3GAP12946NM_012233.3AR
RAB3GAP24182NM_012414.4AR
RECQL43628NM_004260.4AR
RIC13498NM_001135920.4AD
SEC23A2298NM_006364.4AR
SIL11386NM_022464.5AR
SLC16A121551NM_213606.4AD
SLC2A11479
  • Keine OMIM-Gs verknüpft
NM_006516.4AD
SLC33A11650NM_004733.4AR
SMG82988NM_018149.7AR
SRD5A3957NM_024592.5AR
SREBF13534NM_001005291.3AD, AR
TBC1D201212NM_144628.4AR
TKFC2102NM_015533.4AR
VPS4A1325NM_013245.3AD
VSX21086NM_182894.3AR
WFS12673NM_006005.3AD, AR
WRN4299NM_000553.6AR
XYLT22598NM_022167.4AR
ZNF5262013NM_133444.3AR

Infos zur Erkrankung

Klinischer Kommentar

Heterogene Gruppe von Erkrankungen

 

Synonyme
  • Alias: Cataract, syndromal
  • Allelic: Adult i phenotype without cataract (GCNT2)
  • Allelic: Blood group, Ii (GCNT2)
  • Allelic: Cardiomyopathy, dilated, 1II (CRYAB)
  • Allelic: Cataract 38, AR (AGK)
  • Allelic: Deafness, autosomal dominant 37 (COL11A1)
  • Allelic: Dent disease 2 (OCRL)
  • Allelic: Epilepsy, idiopathic generalized, susceptibility to, 12 (SLC2A1)
  • Allelic: Fibrochondrogenesis 1 (COL11A1)
  • Allelic: Lumbar disc herniation, susceptibility to (COL11A1)
  • Allelic: Myopathy, myofibrillar, 2 (CRYAB)
  • Allelic: Premature ovarian insufficiency [panelapp] (PGRMC1)
  • Allelic: Spastic paraplegia 9A, AD (ALDH18A1)
  • Allelic: Spastic paraplegia 9B, AR (ALDH18A1)
  • Allelic: Stickler sydrome, type I, nonsyndromic ocular (COL2A1)
  • Allelic: Stickler syndrome, type II (COL11A1)
  • Allelic: Trichothiodystrophy 1, photosensitive (ERCC2)
  • Allelic: Vitreoretinopathy with phalangeal epiphyseal dysplasia (COL2A1)
  • Allelic: Xeroderma pigmentosum, group D (ERCC2)
  • Lysyl hydroxylase 3 deficiency (PLOD3)
  • 3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement, neutropenia (CLPB)
  • 3-methylglutaconic aciduria, type VIII (HTRA2)
  • AR cataract due to abnormal sterol metabolism [panelapp] (CYP51A1)
  • Acromicric dysplasia (FBN1)
  • Allelic: Pontocereb. hypoplasia, hypotonia, respiratory insufficiency s., neonatal lethal (ATAD3)
  • Alopecia-mental retardation syndrome 4 (LSS)
  • Alport syndrome 1, XL (COL4A5)
  • Alport syndrome 1, XL (COL4A5)
  • Alzahrani-Kuwahara syndrome: global developmental delay ID, poor/absent speech (SMG8)
  • Anterior segment anomalies with/-out cataract (EYA1)
  • Anterior segment dysgenesis 1, multiple subtypes (PITX)
  • Anterior segment dysgenesis 2, multiple subtypes (FOXE3)
  • Anterior segment dysgenesis 3, multiple subtypes (FOXC1)
  • Anterior segment dysgenesis 5, multiple subtypes (PAX6)
  • Anterior segment dysgenesis 7, with sclerocornea (PXDN)
  • Axenfeld-Rieger syndrome, type 3 (FOXC1)
  • Ayme-Gripp syndrome (MAF)
  • Baralle-Macken syndrome: neurodevelopmental disorder, cataracts, var. microcephaly (COPB1)
  • Brain small vessel disease with/-out ocular anomalies (COL4A1)
  • Branchiooculofacial syndrome (TFAP2A)
  • Branchiootorenal syndrome 1, with/-out cataracts (EYA1)
  • CATIFA syndrome: cleft lip, cataract, tooth abnormality, ID, face dysmorph, ADHS (RIC1)
  • CIMDAG syndr.: cereb. hypoplasia, cataract, ID, microceph., dystonia, anemia, red. growth (VPS4A)
  • CODAS [cerebral, ocular, dental, auricular + skeletal anomalies] syndrome (LONP1)
  • Cataract 1, multiple types (GJA8)
  • Cataract 11, multiple types (PITX)
  • Cataract 11, syndromic, AR (PITX)
  • Cataract 13 with adult i phenotype (GCNT2)
  • Cataract 14, multiple types (GJA3)
  • Cataract 15, multiple types (MIP)
  • Cataract 16, multiple types (CRYAB)
  • Cataract 17, multiple types (CRYBB1)
  • Cataract 19 (LIM2)
  • Cataract 2, multiple types (CRYGC)
  • Cataract 21, multiple types (MAF)
  • Cataract 22 (CRYBB3)
  • Cataract 23 (CRYBA4)
  • Cataract 3, multiple types (CRYBB2)
  • Cataract 34, multiple types (FOXE3)
  • Cataract 40, X-linked (NHS)
  • Cataract 41 (WFS1)
  • Cataract 44 (LSS)
  • Cataract 47, juvenile, with microcornea (SLC16A12)
  • Cataract 48 (DNMBP1)
  • Cataract 6, multiple types (EPHA2)
  • Cataract 9, multiple types (CRYAA)
  • Cataract with late-onset corneal dystrophy (PAX6)
  • Cerebrooculofacioskeletal syndrome 2 (ERCC2)
  • Cerebrotendinous xanthomatosis (CYP27A1)
  • Cohen-Gibson syndrome (EED)
  • Congenital cataracts, facial dysmorphism, neuropathy (CTDP1)
  • Congenital cataracts, hearing loss + neurodegeneration (SLC33A1)
  • Congenital disorder of glycosylation, type IIj (COG4)
  • Craniolenticulosutural dysplasia (SEC23A)
  • Cutis laxa, AD (ALDH18A1)
  • Cutis laxa, AR, type IIIA (ALDH18A1)
  • Dentici-Novelli neurodevelopmental syndrome (ZNF526)
  • Developmental + epileptic encephalopathy 71 (GLS
  • Dystonia 9 (SLC2A1)
  • Ectopia lentis, familial (FBN1)
  • Exudative vitreoretinopathy 2, XL (NDP)
  • Fish-eye disease (LCAT)
  • GLUT1 deficiency syndrome 1, infantile onset, severe (SLC2A1)
  • GLUT1 deficiency syndrome 2, childhood onset (SLC2A1)
  • Galactokinase deficiency with cataracts (GALK1)
  • Galactosemia (GALT)
  • Galactosemia IV (GALM)
  • Geleophysic dysplasia 2 (FBN1)
  • Glaucoma, primary closed-angle (COL18A1)
  • Global developmental delay, progressive ataxia + elevated glutamine (GLS)
  • Harel-Yoon syndrome (ATAD3)
  • Hemorrhagic destruction of the brain, subependymal calcification, and cataracts (JAM3)
  • Hyperferritinemia-cataract syndrome (FTL)
  • Hypotrichosis 14 (LSS)
  • ID, cataract; iris, ear, heart, skeletal + choanal morph., AKUT, seizures [panelapp] (CDK9)
  • Ichthyosis, follicular, with atrichia + photophobia syndrome 2 (SREBF1)
  • Infantile cataract, skin abnormalities, glutamate excess, impaired intellectual development (GLS)
  • Intellectual developmental disorder, AD 7 (DYRK1A)
  • Isolated paediatric cataract; Cataract [MONDO:0005129] [panelapp] (PGRMC1)
  • Kahrizi syndrome: mental retardation, cataracts, coloboma, kyphosis, coarse face (SRD5A3)
  • Knobloch syndrome, type 1 (COL18A1)
  • Lathosterolosis (SC5D)
  • Leukodystrophy, hypomyelinating, 5 (FAM126A)
  • Leukoencephalopathy with vanishing white matter (EIF2B2)
  • Lowe syndrome (OCRL)
  • MASS syndrome (FBN1)
  • Macrothrombocytopenia, granulocyte inclusions with/-out nephritis, sensorineural hearing loss (MYH9)
  • Mannosidosis, alpha-, types I, II (MAN2B1)
  • Marfan lipodystrophy syndrome (FBN1)
  • Marfan syndrome (FBN1)
  • Marinesco-Sjogren syndrome (SIL1)
  • Marshall syndrome (COL11A1)
  • Martsolf syndrome (RAB3GAP2)
  • Microcephaly, congenital cataract, psoriasiform dermatitis (MSMO1)
  • Microphthalmia with coloboma 3 (VSX2)
  • Microphthalmia, syndromic 2 (BCOR)
  • Mitochondrial DNA depletion syndrome 4B, Alpers + MNGIE types (POLG)
  • Mitochondrial recessive ataxia syndrome, includes SANDO + SCAE (POLG)
  • Mucoepithelial dysplasia, hereditary (SREBF1)
  • Muscular dystrophy, congenital, cataracts + intellectual disability (INPP5K)
  • Muscular dystrophy-dystroglycanopathy, cong. with ID, type B, 1 (POMT1)
  • Muscular dystrophy-dystroglycanopathy, cong. with brain + eye anomalies, type A, 1 (POMT1)
  • Muscular dystrophy-dystroglycanopathy, cong. with mental retardation, type B, 1 (POMT1)
  • Muscular dystrophy-dystroglycanopathy, limb-girdle, type C, 1 (POMT1)
  • Myopathy, mitochondrial progressive, congenital cataract, developmental delay (GFER)
  • Myopia, high, cataract + vitreoretinal degeneration (P3H2)
  • Myotonic dystrophy 1 (DMPK)
  • Nance-Horan syndrome: cong. cataract, dental anomalies, dysmorphic features, in some cases ID (NHS)
  • Neurodevelopmental disorder with cataracts, poor growth, dysmorphic facies (INTS1)
  • Neurodevelopmental disorder with microcephaly, cataracts + renal abnormalities (GEMIN4)
  • Neurodevelopmental disorder with spasticity, cataracts, cerebellar hypoplasia (MED27)
  • Neurodevelopmental disorder, epilepsy, cataracts, feeding diff., delayed brain myelin. (NACC1)
  • Neurofibromatosis, type 2 (NF2)
  • Norrie disease (NDP)
  • Norum disease (LCAT)
  • Oculoauricular syndrome (HMX1)
  • Oculoskeletodental syndrome (PIK3C2A)
  • Optic atrophy 3 with cataract (OPA3)
  • Ovarioleukodystrophy (EIF2B2)
  • Peroxisomal fatty acyl-CoA reductase 1 disorder (FAR1)
  • Peroxisome biogenesis disorders (PEX...)
  • Peters-plus syndrome (B3GLCT)
  • Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract (ABHD12)
  • Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, cataract (ADAMTS10)
  • Progressive external ophthalmoplegia, AD 1 (POLG)
  • Progressive external ophthalmoplegia, AR 1 (POLG)
  • Rhizomelic chondrodysplasia punctata, type 2 (GNPAT)
  • Rhizomelic chondrodysplasia punctata, type 3 (AGPS)
  • Rothmund-Thomson syndrome, type 1 (ANAPC1)
  • Rothmund-Thomson syndrome, type 2 (RECQL4)
  • Sandestig-Stefanova s.: micro-, trigonoceph., cataract, microphth., face, camptodactyly... (NUP188)
  • Saul-Wilson syndrome (COG4)
  • Sengers syndrome (AGK)
  • Smith-Lemli-Opitz syndrome (DHCR7)
  • Sorbitol dehydrogenase deficiency with peripheral neuropathy (SORD)
  • Spondyloocular syndrome (XYLT2)
  • Stickler syndrome, type I (COL2A1)
  • Stiff skin syndrome (FBN1)
  • Stomatin-deficient cryohydrocytosis with neurologic defects (SLC2A1)
  • Trichothiodystrophy 3, photosensitive (GTF2H5)
  • Triokinase + FMN cyclase deficiency syndrome (TKFC)
  • Vici syndrome (EPG5)
  • Warburg micro syndrome 1 (RAB3GAP1)
  • Warburg micro syndrome 2 (RAB3GAP2)
  • Warburg micro syndrome 3 (RAB18)
  • Warburg micro syndrome 4 (TBC1D20)
  • Weill-Marchesani syndrome 2, AD (FBN1)
  • Weill-Marchesani syndrome 2, dominant (FBN1)
  • Werner syndrome (WRN)
Erbgänge, Vererbungsmuster etc.
  • AD
  • AR
  • Mult
  • XL
  • XLR
  • n.k.
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatik und klinische Interpretation

Test-Stärken

  • DAkkS-akkreditiertes Labor
  • EU-Richtlinie für IVD in Umsetzung
  • Qualitäts-kontrolliert arbeitendes Personal
  • Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
  • Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
  • eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
  • unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
  • unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
  • unsere umfassenden klinischen Aussagen

Testeinschränkungen

  • Gene mit eingeschränkter Abdeckung werden gekennzeichnet
  • Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
  • es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
  • die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
  • Gen-Konversionen
  • komplexe Inversionen
  • Balancierte Translokationen
  • Mitochondriale Varianten
  • Repeat-Expansionen, sofern nicht anders dokumentiert
  • nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
  • niedriger Mosaik-Status
  • Repeat-Blöcke von Mononukleotiden
  • Indels >50bp (Insertionen-Deletionen)
  • Deletionen oder Duplikationen einzelner Exons
  • Varianten innerhalb von Pseudogenen
  • die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde

Laboranforderung

  • Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.

  • Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.

  • Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.

  • Die Untersuchung wird auch für Selbstzahler angeboten.